Cannabis Banking Bill Faces Controversy as Financial Company Revises Testimony, Urging Swift Action
In a surprising turn of events, a marijuana financial services company has revised its testimony on a congressional cannabis banking bill, sparking controversy among advocates and stakeholders. Following pushback over remarks made at a Senate committee hearing, where a compliance officer suggested a “pause” to further amend the legislation, Dama Financial has faced criticism for seemingly undermining efforts to show a united front in advancing the Secure and Fair Enforcement (SAFE) Banking Act. Now, as Dama releases the updated testimony to Banking Committee leadership, they emphasize the urgent need for the bill’s passing and highlight the risks associated with the current financial infrastructure in the cannabis industry.
The status quo of federal prohibition has hindered the cannabis industry’s access to traditional financial services, leading to a reliance on cash transactions that pose significant threats to public safety. Dama Financial’s CEO, Patrick O’Boyle, acknowledges the unnecessary risks of operating primarily with cash, including thefts, robberies, burglaries, and even deaths. By supporting the SAFE Banking Act, federal agencies would be empowered to take action against entities providing financial services to licensed cannabis operators, effectively aligning federal and state law while bolstering the industry’s access to vital financial services and products.
While Dama’s initial testimony focused narrowly on banking compliance, the revised testimony acknowledges the need to strike a balance by highlighting the benefits of the legislation. Dama recognizes that the cannabis industry’s growth is accelerating as more states transition from medical-only to fully legal markets. Therefore, they urge the Senate not to stall the passing of the SAFE Banking Act. By giving financial institutions the ability to work with cannabis businesses, the Senate would not only enhance public safety by reducing cash on the streets but also support smart economic policies that contribute to the country’s financial health.
Kim Rivers, CEO of Trulieve, a multi-state marijuana company, reached out to Dama following their initial committee testimony, seeking assurances that their position would be corrected. Rivers expresses gratitude for Dama’s commitment to revising their testimony and acknowledges that any damage caused by the initial remarks may already be done.
Moving forward, the next step for the SAFE Banking Act is to receive a committee markup, with Senate Majority Leader Chuck Schumer expressing hope that this will happen “in the near future.” The plan is to pass the clean standalone bill out of committee, followed by amendments on the floor. Schumer and his colleagues emphasize the importance of incorporating “criminal justice” provisions such as record expungements for individuals with prior marijuana convictions. Additionally, concerns raised by Democratic senators, federal officials, and consumer advocacy groups may lead to amendments addressing specific provisions that could inadvertently limit regulators’ ability to take action against those exploiting banking services.
A coalition of groups has called for an expansion of the bill’s financial protections to allow the cannabis industry access to major U.S. stock exchanges. However, this request has faced criticism from advocates who argue that such a move would be premature while efforts to legalize marijuana stall in Congress.
Sen. Jacky Rosen (D-NV) also supports the SAFE Banking Act and seeks to amend it to enable cannabis businesses to access federal Small Business Administration (SBA) services. Senate lawmakers, including Sen. Cory Booker (D-NJ), are determined to resurrect the cannabis reform package and avoid the closure of numerous businesses resulting from the lack of a banking fix.
Rep. Earl Blumenauer (D-OR), a lead sponsor of the House version of the SAFE Banking Act, emphasizes the importance of incremental proposals to end the drug war. He warns against an “all-or-nothing” approach, urging advocates and lawmakers to align on necessary reforms.
The American Bankers Association (ABA) and its state chapters, along with insurance and union organizations, have also renewed their calls for the passage of the legislation. With over 1,000 cannabis, psychedelics, and drug policy bills being tracked, it remains crucial for supporters to stay informed and engaged in the ongoing developments surrounding the cannabis industry.
By addressing the controversies surrounding the revised testimony, stakeholders and lawmakers can work towards a common goal of securing the future of the cannabis industry through the passage of the SAFE Banking Act.
